Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Multiple Sclerosis Market Size Growth Rate by Type (2014-2025) 1.4.2 Injectable agents 1.4.3 Oral agents 1.5 Market by Application 1.5.1 Global Multiple Sclerosis Market Share by Application (2014-2025) 1.5.2 Hosptial 1.5.3 Research 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Multiple Sclerosis Market Size 2.2 Multiple Sclerosis Growth Trends by Regions 2.2.1 Multiple Sclerosis Market Size by Regions (2014-2025) 2.2.2 Multiple Sclerosis Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Multiple Sclerosis Market Size by Manufacturers 3.1.1 Global Multiple Sclerosis Revenue by Manufacturers (2014-2019) 3.1.2 Global Multiple Sclerosis Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Multiple Sclerosis Market Concentration Ratio (CR5 and HHI) 3.2 Multiple Sclerosis Key Players Head office and Area Served 3.3 Key Players Multiple Sclerosis Product/Solution/Service 3.4 Date of Enter into Multiple Sclerosis Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Multiple Sclerosis Market Size by Type (2014-2019) 4.2 Global Multiple Sclerosis Market Size by Application (2014-2019) 5 United States 5.1 United States Multiple Sclerosis Market Size (2014-2019) 5.2 Multiple Sclerosis Key Players in United States 5.3 United States Multiple Sclerosis Market Size by Type 5.4 United States Multiple Sclerosis Market Size by Application 6 Europe 6.1 Europe Multiple Sclerosis Market Size (2014-2019) 6.2 Multiple Sclerosis Key Players in Europe 6.3 Europe Multiple Sclerosis Market Size by Type 6.4 Europe Multiple Sclerosis Market Size by Application 7 China 7.1 China Multiple Sclerosis Market Size (2014-2019) 7.2 Multiple Sclerosis Key Players in China 7.3 China Multiple Sclerosis Market Size by Type 7.4 China Multiple Sclerosis Market Size by Application 8 Japan 8.1 Japan Multiple Sclerosis Market Size (2014-2019) 8.2 Multiple Sclerosis Key Players in Japan 8.3 Japan Multiple Sclerosis Market Size by Type 8.4 Japan Multiple Sclerosis Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Multiple Sclerosis Market Size (2014-2019) 9.2 Multiple Sclerosis Key Players in Southeast Asia 9.3 Southeast Asia Multiple Sclerosis Market Size by Type 9.4 Southeast Asia Multiple Sclerosis Market Size by Application 10 India 10.1 India Multiple Sclerosis Market Size (2014-2019) 10.2 Multiple Sclerosis Key Players in India 10.3 India Multiple Sclerosis Market Size by Type 10.4 India Multiple Sclerosis Market Size by Application 11 Central & South America 11.1 Central & South America Multiple Sclerosis Market Size (2014-2019) 11.2 Multiple Sclerosis Key Players in Central & South America 11.3 Central & South America Multiple Sclerosis Market Size by Type 11.4 Central & South America Multiple Sclerosis Market Size by Application 12 International Players Profiles 12.1 Abbvie 12.1.1 Abbvie Company Details 12.1.2 Company Description and Business Overview 12.1.3 Multiple Sclerosis Introduction 12.1.4 Abbvie Revenue in Multiple Sclerosis Business (2014-2019) 12.1.5 Abbvie Recent Development 12.2 Acorda Therapeutics 12.2.1 Acorda Therapeutics Company Details 12.2.2 Company Description and Business Overview 12.2.3 Multiple Sclerosis Introduction 12.2.4 Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019) 12.2.5 Acorda Therapeutics Recent Development 12.3 Bayer HealthCare 12.3.1 Bayer HealthCare Company Details 12.3.2 Company Description and Business Overview 12.3.3 Multiple Sclerosis Introduction 12.3.4 Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019) 12.3.5 Bayer HealthCare Recent Development 12.4 Biogen 12.4.1 Biogen Company Details 12.4.2 Company Description and Business Overview 12.4.3 Multiple Sclerosis Introduction 12.4.4 Biogen Revenue in Multiple Sclerosis Business (2014-2019) 12.4.5 Biogen Recent Development 12.5 Genzyme (Sanofi) 12.5.1 Genzyme (Sanofi) Company Details 12.5.2 Company Description and Business Overview 12.5.3 Multiple Sclerosis Introduction 12.5.4 Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019) 12.5.5 Genzyme (Sanofi) Recent Development 12.6 GlaxoSmithKline 12.6.1 GlaxoSmithKline Company Details 12.6.2 Company Description and Business Overview 12.6.3 Multiple Sclerosis Introduction 12.6.4 GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019) 12.6.5 GlaxoSmithKline Recent Development 12.7 Merck Serono 12.7.1 Merck Serono Company Details 12.7.2 Company Description and Business Overview 12.7.3 Multiple Sclerosis Introduction 12.7.4 Merck Serono Revenue in Multiple Sclerosis Business (2014-2019) 12.7.5 Merck Serono Recent Development 12.8 Novartis 12.8.1 Novartis Company Details 12.8.2 Company Description and Business Overview 12.8.3 Multiple Sclerosis Introduction 12.8.4 Novartis Revenue in Multiple Sclerosis Business (2014-2019) 12.8.5 Novartis Recent Development 12.9 Pfizer 12.9.1 Pfizer Company Details 12.9.2 Company Description and Business Overview 12.9.3 Multiple Sclerosis Introduction 12.9.4 Pfizer Revenue in Multiple Sclerosis Business (2014-2019) 12.9.5 Pfizer Recent Development 12.10 Teva 12.10.1 Teva Company Details 12.10.2 Company Description and Business Overview 12.10.3 Multiple Sclerosis Introduction 12.10.4 Teva Revenue in Multiple Sclerosis Business (2014-2019) 12.10.5 Teva Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Multiple Sclerosis Key Market Segments Table Key Players Multiple Sclerosis Covered Table Global Multiple Sclerosis Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Multiple Sclerosis Market Size Market Share by Type 2014-2025 Figure Injectable agents Figures Table Key Players of Injectable agents Figure Oral agents Figures Table Key Players of Oral agents Table Global Multiple Sclerosis Market Size Growth by Application 2014-2025 (Million US$) Figure Hosptial Case Studies Figure Research Case Studies Figure Multiple Sclerosis Report Years Considered Table Global Multiple Sclerosis Market Size 2014-2025 (Million US$) Figure Global Multiple Sclerosis Market Size and Growth Rate 2014-2025 (Million US$) Table Global Multiple Sclerosis Market Size by Regions 2014-2025 (Million US$) Table Global Multiple Sclerosis Market Size by Regions 2014-2019 (Million US$) Table Global Multiple Sclerosis Market Share by Regions 2014-2019 Figure Global Multiple Sclerosis Market Share by Regions 2014-2019 Figure Global Multiple Sclerosis Market Share by Regions 2019 Table Market Top Trends Table Global Multiple Sclerosis Revenue by Manufacturers (2014-2019) (Million US$) Table Global Multiple Sclerosis Market Share by Manufacturers (2014-2019) Figure Global Multiple Sclerosis Market Share by Manufacturers in 2018 Table Global Multiple Sclerosis Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Multiple Sclerosis Product/Solution/Service Table Date of Enter into Multiple Sclerosis Market Table Mergers & Acquisitions, Expansion Plans Table Global Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table Global Multiple Sclerosis Market Size Share by Type (2014-2019) Figure Global Multiple Sclerosis Market Size Market Share by Type (2014-2019) Table Global Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table Global Multiple Sclerosis Market Size Share by Application (2014-2019) Figure Global Multiple Sclerosis Market Size Market Share by Application (2014-2019) Figure Global Multiple Sclerosis Revenue Market Share by Application in 2018 Figure United States Multiple Sclerosis Market Size 2014-2019 (Million US$) Table United States Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table United States Key Players Multiple Sclerosis Market Share (2018-2019) Table United States Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table United States Multiple Sclerosis Market Share by Type (2014-2019) Table United States Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table United States Multiple Sclerosis Market Share by Application (2014-2019) Figure Europe Multiple Sclerosis Market Size 2014-2019 (Million US$) Table Europe Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table Europe Key Players Multiple Sclerosis Market Share (2018-2019) Table Europe Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table Europe Multiple Sclerosis Market Share by Type (2014-2019) Table Europe Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table Europe Multiple Sclerosis Market Share by Application (2014-2019) Figure China Multiple Sclerosis Market Size 2014-2019 (Million US$) Table China Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table China Key Players Multiple Sclerosis Market Share (2018-2019) Table China Multiple Sclerosis Market Size by Type (2014-20189) (Million US$) Table China Multiple Sclerosis Market Share by Type (2014-2019) Table China Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table China Multiple Sclerosis Market Share by Application (2014-2019) Figure Japan Multiple Sclerosis Market Size 2014-2019 (Million US$) Table Japan Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table Japan Key Players Multiple Sclerosis Market Share (2018-2019) Table Japan Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table Japan Multiple Sclerosis Market Share by Type (2014-2019) Table Japan Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table Japan Multiple Sclerosis Market Share by Application (2014-2019) Figure Southeast Asia Multiple Sclerosis Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Multiple Sclerosis Market Share (2018-2019) Table Southeast Asia Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Multiple Sclerosis Market Share by Type (2014-2019) Table Southeast Asia Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Multiple Sclerosis Market Share by Application (2014-2019) Figure India Multiple Sclerosis Market Size 2014-2019 (Million US$) Table India Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table India Key Players Multiple Sclerosis Market Share (2018-2019) Table India Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table India Multiple Sclerosis Market Share by Type (2014-2019) Table India Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table India Multiple Sclerosis Market Share by Application (2014-2019) Figure Central & South America Multiple Sclerosis Market Size 2014-2019 (Million US$) Table Central & South America Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$) Table Central & South America Key Players Multiple Sclerosis Market Share (2018-2019) Table Central & South America Multiple Sclerosis Market Size by Type (2014-2019) (Million US$) Table Central & South America Multiple Sclerosis Market Share by Type (2014-2019) Table Central & South America Multiple Sclerosis Market Size by Application (2014-2019) (Million US$) Table Central & South America Multiple Sclerosis Market Share by Application (2014-2019) Table Abbvie Company Details Table Abbvie Revenue in Multiple Sclerosis Business (2014-2019) (Million US$) Figure Abbvie Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Abbvie Recent Development Table Acorda Therapeutics Company Details Table Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Acorda Therapeutics Recent Development Table Bayer HealthCare Company Details Table Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Bayer HealthCare Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Bayer HealthCare Recent Development Table Biogen Company Details Table Biogen Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Biogen Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Biogen Recent Development Table Genzyme (Sanofi) Company Details Table Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Genzyme (Sanofi) Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Genzyme (Sanofi) Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table GlaxoSmithKline Recent Development Table Merck Serono Company Details Table Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Merck Serono Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Merck Serono Recent Development Table Novartis Company Details Table Novartis Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Pfizer Recent Development Table Teva Company Details Table Teva Revenue in Multiple Sclerosis Business (2014-2019)(Million US$) Figure Teva Revenue Growth Rate in Multiple Sclerosis Business (2014-2019) Table Teva Recent Development Table Global Multiple Sclerosis Market Size by Regions (Million US$) 2019-2025 Figure Global Multiple Sclerosis Market Size Share by Regions (2019-2025) Figure Global Multiple Sclerosis Market Size Share by Regions in 2025 Figure United States Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Figure Europe Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Figure China Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Figure Japan Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Figure India Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD) Table Global Multiple Sclerosis Market Size by Product (2019-2025) (Million US$) Figure Global Multiple Sclerosis Market Size by Product (2019-2025) Figure Global Multiple Sclerosis Market Size by Product in 2025 Table Global Multiple Sclerosis Market Size by Application (2019-2025) (Million US$) Figure Global Multiple Sclerosis Market Size by Application (2019-2025) Figure Global Multiple Sclerosis Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbvie Acorda Therapeutics Bayer HealthCare Biogen Genzyme (Sanofi) GlaxoSmithKline Merck Serono Novartis Pfizer Teva